Company Monitoring Page for Eli-Lilly

latest headlines for company on cafepharma

Hostile Takeovers And The Race To Reduce Residual Risk In Heart Disease Patients
Seeking Alpha
Wed, 06/20/12 - 12:38 pm
Tags:
M&A, heart disease, Human Genome Sciences, Amylin, GSK, Eli Lilly, Merck, Novo Nordisk, Pfizer
Survey shows dim faith in Lilly, Pfizer Alzheimer's drugs
Reuters
Wed, 06/20/12 - 11:48 am
Tags:
Eli Lilly, Pfizer, Alzheimer's disease, solanezumab, bapineuzumab
Lilly resumes share buybacks after long absence
Reuters
Tue, 06/19/12 - 11:55 am
Tags:
share repurchase, Eli Lilly
Merck: Can 5 New Drugs Fill Singulair Gap?
Seeking Alpha
Tue, 06/19/12 - 10:21 am
Tags:
Merck, Singulair, Pfizer, AstraZeneca, Sanofi, Forest Labs, Bristol-Myers Squibb, suvorexant, Eli Lilly, Bridon, V503, Endocyte, Tredaptive
Eli Lilly in Great Position with New Drug Amyvid
Motley Fool
Mon, 06/18/12 - 02:45 pm
Tags:
Amyvid, Eli Lilly
Who Got The Most Buzz At The Diabetes Show?
Pharmalot
Wed, 06/13/12 - 12:05 pm
Tags:
ADA, diabetes, JNJ, Eli Lilly, Novo Nordisk, Sanofi, Bristol-Myers Squibb
8 Major Healthcare Stocks Yielding At Least 3.9% With P/E Ratios Under 18
Seeking Alpha
Tue, 06/12/12 - 11:03 am
Tags:
AstraZeneca, Bristol-Myers Squibb, GSK, JNJ, Eli Lilly, Merck, Novartis, Pfizer
China Biotech Week In Review: Mindray Medical Continues On Acquisition Path
Seeking Alpha
Sun, 06/10/12 - 11:17 am
Tags:
Mindray, ShangPharma, Eli Lilly, WuXi PharmaTech, Hutchison MediPharma, Chi-Med
Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company present new linagliptin data at American Diabetes Association's 72nd Scientific Sessions®
Yahoo/PR NewsWire
Sun, 06/10/12 - 11:10 am
Tags:
linagliptin, type 2 diabetes, Boehringer Ingelheim, Eli Lilly
Lilly and Incyte's Oral JAK1 and JAK2 Inhibitor
PharmPro
Sat, 06/9/12 - 04:54 pm
Tags:
Eli Lilly, Incyte, LY3009104, baricitinib, rheumatoid arthritis
Lilly and Incyte's Oral JAK1 and JAK2 Inhibitor, Baricitinib, Showed Positive Results in Phase IIb Study in Patients with Active Rheumatoid Arthritis
Yahoo
Fri, 06/8/12 - 01:28 pm
Tags:
Incyte, JAK inhibitors, baricitinib, Eli Lilly, rheumatoid arthritis
Eli Lilly CEO Says No Big Deals
WSJ Online
Wed, 06/6/12 - 05:29 pm
Tags:
John Lechleiter, Pharma CEOs, Eli Lilly, M&A
Eli Lilly Launches Amyvid
Yahoo/Zacks
Mon, 06/4/12 - 05:42 pm
Tags:
Eli Lilly, Amyvid, Alzheimer's disease
3 Reasons To Consider Eli Lilly
Seeking Alpha
Sun, 06/3/12 - 12:40 pm
Tags:
Eli Lilly
Kowa Pharma, Eli Lilly PREVAIL US study of Livalo met primary endpoint of LDL-C reduction
Pharmabiz
Sun, 06/3/12 - 12:35 pm
Tags:
Eli Lilly, Livalo, hypercholesterolemia, LDL cholesterol
CHMP in Favor of Lilly's Jentadueto
Yahoo/Zacks
Fri, 06/1/12 - 12:24 pm
Tags:
Eli Lilly, Jentadueto, CHMP, diabetes
New Drug Could Push AstraZeneca 20% Higher
Seeking Alpha
Thu, 05/31/12 - 09:38 am
Tags:
AstraZeneca, JNJ, Bristol-Myers Squibb, Eli Lilly, Pfizer, Sanofi, GSK
With Plavix gone generic, payers aim to cut Effient, Brilinta
Fierce Pharma
Wed, 05/30/12 - 11:30 am
Tags:
generics, Effient, Plavix, Brilinta, Eli Lilly, bloodthinners, AstraZeneca, Sanofi, Bristol-Myers Squibb
Sanofi, Novo, Lilly shape up for big insulin fight
Reuters
Wed, 05/30/12 - 10:25 am
Tags:
Sanofi, Novo Nordisk, Eli Lilly, diabetes, insulin, Lantus
Biotechnology Stocks To Watch Ahead Of ASCO 2012: Part 1
Seeking Alpha
Thu, 05/24/12 - 12:53 pm
Tags:
ASCO, Eli Lilly, Galena Biopharma, Dendreon, Exelixis, CytRx, Array Biopharma, Ariad Pharmaceuticals

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.